HDFC BSE 500 Index Fund
IPCA Laboratories Limited · NSE
2,274 sh · ₹39.73 L
HDFC Mid Cap Fund
3.0% of their portfolio
₹3,162.93 Cr
1,80,96,628 sh
Nippon India Growth Mid Cap Fund
1.1% of their portfolio
₹541.82 Cr
31,00,000 sh
HDFC Mutual Fund (scheme HDFCGR)
40.0% of their portfolio
₹436.45 Cr
24,97,123 sh
HDFC Large and Mid Cap Fund
82.0% of their portfolio
₹246.22 Cr
14,08,766 sh
Nippon India Pharma Fund
2.6% of their portfolio
₹238.53 Cr
13,64,742 sh
Nippon India Multi Cap Fund
0.4% of their portfolio
₹219.37 Cr
12,55,095 sh
HDFC Mutual Fund (scheme HDFCGF)
1.2% of their portfolio
₹130.15 Cr
7,44,642 sh
HDFC Multi Cap Fund
51.0% of their portfolio
₹104.58 Cr
5,98,332 sh
HDFC Pharma and Healthcare Fund
3.2% of their portfolio
₹94.68 Cr
5,41,736 sh
Nippon India Vision Large & Mid Cap Fund
1.0% of their portfolio
₹75.57 Cr
4,32,355 sh
Nippon India Balanced Advantage Fund
0.7% of their portfolio
₹73.52 Cr
4,20,646 sh
Aditya Birla Sun Life Midcap Fund
0.7% of their portfolio
₹49.22 Cr
2,89,373 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
HDFC BSE 500 Index Fund
IPCA Laboratories Limited · NSE
2,274 sh · ₹39.73 L
ICICI Prudential Nifty Healthcare ETF
IPCA Laboratories Limited · NSE
28,365 sh · ₹4.96 Cr
HDFC Nifty LargeMidcap 250 Index Fund
IPCA Laboratories Limited · NSE
7,591 sh · ₹1.33 Cr
ICICI Prudential Nifty Midcap 150 Index Fund
IPCA Laboratories Limited · NSE
42,042 sh · ₹7.35 Cr
ICICI Prudential Nifty Pharma Index Fund
IPCA Laboratories Limited · NSE
20,798 sh · ₹3.64 Cr
SBI Nifty 500 Index Fund
IPCA Laboratories Limited · NSE
5,425 sh · ₹94.82 L
ICICI Prudential Nifty LargeMidcap 250 Index Fund
IPCA Laboratories Limited · NSE
4,908 sh · ₹85.78 L
Nippon India Nifty 500 Equal Weight Index Fund
IPCA Laboratories Limited · NSE
5,711 sh · ₹99.82 L
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
16 announcements on record for this company.
2,37,346 sh
Promoter holding by quarter: Jun 2025 44.7%, Sep 2025 44.7%, Dec 2025 44.7%, Mar 2026 44.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 10.7%, Sep 2025 10.4%, Dec 2025 10.6%, Mar 2026 10.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +0.1pp
DII holding by quarter: Jun 2025 35.9%, Sep 2025 36.5%, Dec 2025 37.0%, Mar 2026 37.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.7pp
MF holding by quarter: Jun 2025 29.6%, Sep 2025 30.0%, Dec 2025 30.5%, Mar 2026 31.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Nippon India Nifty Midcap 150 Index Fund
IPCA Laboratories Limited · NSE
91,205 sh · ₹15.94 Cr
HDFC Pharma and Healthcare Fund
IPCA Laboratories Limited · NSE
5,41,736 sh · ₹94.68 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 44.7%, Sep 2025 44.7%, Dec 2025 44.7%, Mar 2026 44.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 10.7%, Sep 2025 10.4%, Dec 2025 10.6%, Mar 2026 10.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +0.1pp
DII holding by quarter: Jun 2025 35.9%, Sep 2025 36.5%, Dec 2025 37.0%, Mar 2026 37.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.7pp
MF holding by quarter: Jun 2025 29.6%, Sep 2025 30.0%, Dec 2025 30.5%, Mar 2026 31.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
16 announcements on record for this company.